FDA Approves Topical Treatment Addressing Repigmentation in Vitiligo in Patients Aged 12 and Older – Drug Information Update
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Only registered members have full access to PracticeUpdate content.